AXA DBIO GP S.à r.l.
AXA DBIO GP S.à r.l. | |
|---|---|
| Corporate identity | |
| Type | Société à responsabilité limitée (S.à r.l.) |
| Registration number | R.C.S. Luxembourg B 149.162 |
| Regulated | No |
| License type | Holding / General Partner vehicle |
| Incorporation | 2009 |
| Headquarters | 21, boulevard Grande-Duchesse Charlotte, L-1331 Luxembourg |
| Country | Luxembourg |
| Ultimate parent | AXA SA |
| Group status | Subsidiary |
| Business & markets | |
| Operating status | Active |
| Lines of business | Holding / general partner role for AXA DBIO structure |
🏢 AXA DBIO GP S.à r.l. is a Luxembourg S.à r.l. registered under R.C.S. Luxembourg B 149.162 with its registered office at 21, boulevard Grande-Duchesse Charlotte, L-1331 Luxembourg.[1] Incorporated on 9 November 2009, the entity was renamed from AXA LM GP S.à r.l. to its current name following an extraordinary general meeting on 4 April 2012. It functions as the general partner and manager vehicle within the AXA DBIO structure, a run-off and legacy investment platform ultimately controlled by AXA SA, whose status as ultimate parent is confirmed in AXA public legal disclosures.[2] The entity is wholly owned by AXA Liabilities Managers and is not itself subject to a regulated financial-services authorisation. No standalone financial statements were identified in publicly available sources, so revenue, asset, and profit figures remain undisclosed at entity level.[1]
References
- ↑ 1.0 1.1 "Mémorial C — AXA DBIO GP S.à r.l. (formerly AXA LM GP S.à r.l.)" (PDF). Mémorial C, Journal Officiel du Grand-Duché de Luxembourg. 2012. Retrieved 12 March 2026.
- ↑ "Legal Information — AXA". AXA SA. Retrieved 12 March 2026.